How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment.

How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment. Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S8-S11 Authors: Gupta S, Maude SL, O'Brien MM, Rau RE, McNeer JL PMID: 32862880 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32862880?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - August 31, 2020 Category: Cancer & Oncology Authors: Gupta S, Maude SL, O'Brien MM, Rau RE, McNeer JL Tags: Clin Lymphoma Myeloma Leuk Source Type: research

More News: Cancer & Oncology | Immunotherapy | Lymphoma | Myeloma